Hair Loss From the Pill: Causes, Coming Off It, Switching Pills and What Actually Helps

Can the pill cause hair loss?

Yes, the pill can cause hair loss, and the product information says so too: the summary of product characteristics for Yasmin (ethinylestradiol and drospirenone, Bayer) lists alopecia as an uncommon side effect, meaning in more than 1 in 1,000 and fewer than 1 in 100 users.

Four situations qualify as triggers: starting the pill, switching pills, stopping the pill and switching to an oestrogen-free product such as a mini-pill, hormonal coil, implant or contraceptive injection. The most common and best documented of these is stopping the pill.

One point is key to putting this in context: hair loss from the pill does not destroy hair roots. The hormonal change only shifts the proportion of hairs that are in the resting phase at the same time. Normally that is around 10 per cent of scalp hairs (Asghar et al., Cureus 2020), and with an effluvium it is clearly more. That is why the process is reversible in principle.

Losing 50 to 100 hairs a day is normal, because 85 to 90 per cent of follicles are in the growth phase and only 5 to 15 per cent are in the resting or transition phase (Cleveland Clinic). With telogen effluvium the number stays above that for weeks without bald patches forming: the hair thins evenly all over. If you have very heavy hair loss over several months, it is worth keeping a written record of how it develops.

There is a second, opposite question on this topic: some women are not looking for the pill as a cause, but for the pill against hair loss. Both rest on the same mechanism, and both are covered in this article. Hair loss in women also rarely has just one single cause.

The overview below places the four triggers side by side. It also shows where the literature provides solid figures and where it does not.

How does the pill affect the hair? Oestrogen, progestogen and SHBG

The pill acts on the hair through two levers: the oestrogen extends the growth phase, and the progestogen, through its androgenic or antiandrogenic partial activity, determines how much strain each individual follicle is under. Once you understand these two levers, you also understand why the same group of active ingredients appears once as a trigger and once as a treatment.

Lever 1: the oestrogen. Oestrogens extend the anagen phase, that is, the growth phase of the hair. This is seen most clearly in pregnancy, when hair often looks denser and then sheds more heavily after the birth. On a combination pill, the same effect works in a weaker form.

When the oestrogen influence falls away, this artificially extended growth phase ends for many hairs at the same time. They enter the resting phase in sync, and because that phase lasts around three to five months (Asghar et al., Cureus 2020), they also fall out in sync. That is the whole trick behind the delay.

Lever 2: SHBG and the progestogen. In the liver, ethinylestradiol increases the production of SHBG, a transport protein that binds free testosterone. For combinations of levonorgestrel and ethinylestradiol, roughly a doubling of SHBG binding activity has been described; for desogestrel-containing products, clearly higher increases have been reported.

Less free testosterone means less substrate for conversion into DHT at the hair follicle. In the same line of research, total testosterone fell by around 41 per cent and free testosterone by around 55 per cent compared with the baseline value. The values vary considerably between products, so a single percentage does not apply to all of them.

After stopping, this reverses: SHBG falls back to its baseline value within a few weeks to months, and free testosterone rises in relative terms. The literature does not provide an exact day count for this, but the direction is pharmacologically undisputed. More on the connections between hormones and hair can be found in our separate guide.

The point that is usually missing: It is not the pill as a category that decides what happens to the hair, but the partial activity of the progestogen it contains. The pharmacological literature divides these roughly into three groups, although the sources contradict each other on the middle group. That very inconsistency belongs in the overview.

How to find your active ingredient: What counts is not the brand name on the packet, but the “active ingredients” section of the patient information leaflet. That is where the oestrogen and the progestogen are named. Only then can you place your old and your new product in the overview above at all.

What happens at the follicle, by the way, is always the same pattern: a diffuse effluvium across the whole scalp, not patchy loss. This observation matters more than any list of ingredients, because it sets the direction for the investigation.

Hair loss since starting the pill: is that normal?

Hair loss that starts two to four months after you begin taking the pill is typically a transitional effluvium and settles again within about six months in many cases. It is the same telogen kinetics as after stopping, just triggered in the other direction.

The shedding tends to persist in one particular scenario: when the progestogen has androgenic partial activity and there is a family predisposition to pattern hair loss. Then it is no longer an adjustment effect, but an intensification of what was already there.

In the first few months it makes sense to observe rather than act: a photo of your parting in the same light every four weeks, plus your measured ponytail circumference with the date. These two records are what your doctor’s appointment will later build on, because they show a course over time rather than a single snapshot.

Do more hairs fall out during the pill-free break?

During the seven pill-free days, many women watch themselves particularly closely and blame the break for every hair in the brush. Mechanistically, that does not add up: the hormone drop during the break is too short to end the growth phase of larger groups of follicles.

Then there is the latency. Even if the break were a trigger, the shedding could not show up in the same week because of the two- to three-month delay. There is no solid study specifically on the pill-free break and hair loss.

If the shedding is still unchanged after six months, that is a reason to talk to your GP or sexual health clinic, not a reason to stop on your own. An unplanned discontinuation has consequences that go far beyond the hair.

How long does hair loss after stopping the pill last?

Hair loss after stopping the pill typically starts two to three months after the last packet, reaches its peak after about three to four months and normally settles within six to twelve months. The latency of two to three months is described in peer-reviewed form for acute telogen effluvium (Asghar et al., Cureus 2020); the details of the specifically pill-related course come predominantly from clinical experience, not from controlled cohort studies.

The mechanism in one sentence: the loss of the oestrogen influence ends the extended growth phase for many hairs at the same time, they enter the resting phase in sync and they fall out in sync. The technical term for this is telogen effluvium, and in everyday language you hear “post-pill shedding”.

For your peace of mind, the most important thing to know is the sequence: the moment that feels worst and the start of recovery happen at the same time. When you are finding the most hair in your brush, the first follicles are already back in the growth phase. The timeline shows this month by month.

Is post-pill syndrome real?

“Post-pill syndrome” circulates in forums and on supplement websites, but it is not a recognised medical diagnosis. Behind it lie real processes that can each be named separately: the return of your own cycle, the reappearance of acne, a previously masked PCOS becoming visible, and telogen effluvium.

This distinction is not mere hair-splitting. If you name the four processes separately, you can have them investigated separately. If you bundle them into a syndrome, you quickly end up with expensive all-in packages and no findings.

Why doesn’t the hair loss stop after coming off the pill?

If hair loss after stopping the pill continues beyond twelve months, there is usually a second trigger behind it. The most common one is iron deficiency: along with your own cycle, your period returns at its normal strength, and after years of light withdrawal bleeds your stores are depleted.

A second effluvium like this overlaps the first in time and stretches the course beyond the usual six to twelve months. From the outside it looks like shedding that simply will not end; in reality there are two causes one after the other.

That is why ferritin should be checked early, not only after a year of waiting. How iron deficiency and hair loss are connected, and which values are discussed in that context, is covered in our separate article.

The second explanation for shedding that does not stop is a hereditary form that was previously masked by the pill. It does not follow a timeline; it persists. The comparison further down shows how to tell the two apart.

Is it worth tapering off the pill?

Tapering the dose is not an option with combination products, and there is no evidence for it when it comes to the hair either. The change in the hair cycle depends on the hormone level falling away, not on how quickly you stop. Whether and how you stop is a decision for your GP or sexual health clinic anyway.

When does it stop on its own and when does it not?

An effluvium is self-limiting: the density comes back, and the regrowing hairs have normal thickness again. An unmasked hereditary form, by contrast, does not stop on its own. In terms of quantity the shedding is often less dramatic, but the centre parting gets wider and the new hairs vary in thickness.

Special cases: trying to conceive, and stopping from your mid-40s

Anyone who stops the pill in order to get pregnant often has several factors at once: the hormonal change, often a change in diet and, not uncommonly, a fair amount of stress. All three can encourage telogen effluvium. That makes the search for the cause messier, but it does not change the timeline.

When you stop from your mid-40s onwards, post-discontinuation effluvium and perimenopause overlap. Both lower the oestrogen influence, and both show up diffusely. What else happens to the hair in this phase of life is covered in our guide to hair loss during menopause.

Why does hair loss happen after switching pills?

Hair loss after switching pills has two possible reasons. First, a short transitional effluvium with the typical delay described above. Second, a genuine difference in effect, when the new product contains a progestogen with weaker antiandrogenic or stronger androgenic partial activity.

There is no separate body of evidence for this: no systematic timeline has been recorded for switching pills. What can be said follows mechanistically from the telogen kinetics and from the partial activity of the progestogens involved. That honesty is worth more than an invented number.

The unmasking effect. A pill with an antiandrogenic effect can mask an existing predisposition for years. After a switch, the hair loss is then not newly triggered, it is simply no longer suppressed. What that means for your expectations: in this case the shedding does not disappear on its own.

This becomes practical with the patient information leaflet. Compare the active ingredient in your old and your new product and place both in the progestogen overview above. If the old product was antiandrogenic and the new one androgenic, you at least have a plausible explanation to take to your appointment.

Switch back? That is a decision for your GP or sexual health clinic alone, and they will also weigh up the original reason for the switch. Even after switching back, it takes months again for the hair cycle to adjust. Other forms of hormonally related hair loss follow the same time pattern.

Can the mini-pill cause hair loss?

The mini-pill and hair loss are connected through the same mechanism as with the combination pill, but without the counterpart: progestogen-only products contain no oestrogen, so the SHBG effect that binds free testosterone is missing. Here too, alopecia appears in the summary of product characteristics, for desogestrel 75 micrograms as “uncommon” (Swiss summary of product characteristics for Cerazette).

The oestrogen-free products differ from one another: there are mini-pills with desogestrel, with drospirenone and with levonorgestrel, and these progestogens have different partial activities. No recommendation can be derived from that, because the choice of contraception depends on medical criteria that go far beyond the hair.

The most common trigger in practice in this group is switching from the combination pill to an oestrogen-free product, for example while breastfeeding, in cases of migraine with aura, in smokers over 35 or when there is an increased risk of thrombosis. That explains why many women report that “it started with the mini-pill”: the trigger is the loss of the oestrogen, not the new progestogen on its own.

Special case, the hormonal coil: hair loss despite a local effect?

The hormonal coil releases levonorgestrel mainly locally in the uterus, but a small proportion still reaches the bloodstream. A pharmacokinetic analysis of more than 3,400 women from ten studies shows serum levels many times lower than those with oral use (Apter et al., Eur J Contracept Reprod Health Care 2020). Hair loss is nevertheless described as a side effect.

Many women do not count the coil as hormonal contraception at all and therefore look elsewhere for the cause. The same pattern applies here as with the mini-pill: levonorgestrel has androgenic partial activity, there is no oestrogen as a counterpart, and anyone who was previously on a combination pill also loses the SHBG effect with the switch.

The timing helps with the interpretation: an effluvium that begins around three months after insertion fits the hormonal change, whereas shedding two years later does not. What counts in the end is not the method itself, but how sensitively your follicles react to androgens. That belongs in the conversation with your GP too, and not in a self-diagnosis.

And what about the implant, the injection, the ring or the patch?

The contraceptive implant (etonogestrel) and the three-monthly contraceptive injection act systemically and are progestogen-dominant, that is, without an oestrogen counterpart. The vaginal ring and the patch contain an oestrogen-progestogen combination and behave like a combination pill as far as the hair is concerned. The copper coil is hormone-free, but it can strain your iron balance through heavier bleeding and act on the hair indirectly that way.

Which method is “better for the hair” is deliberately not stated here. That is a decision for your GP or sexual health clinic, taking into account thrombosis risk, tolerability, your cycle, pre-existing conditions and your life situation.

Can the pill also just make hair thinner?

Thinning hair from the pill is not the same as hair loss. With an effluvium, many hairs fall out and grow back at normal thickness. With androgenic strain, barely more falls out than the usual 50 to 100 hairs a day, but the individual hairs become finer, shorter and lighter with every cycle. The technical term for this is miniaturisation.

For the prognosis, that is the decisive distinction: one is reversible and ends on its own, the other progresses slowly without treatment. So it is more useful to look at the hairs than to count them.

Three observations help with this, and none of them needs any equipment. First, the ponytail circumference: measure it with a tape measure, write it down, repeat every three months. Second, the photo: same camera, same light, same parting, every four weeks. Third, compare the shed hairs on a light cloth.

If the shed hairs are evenly thick and carry a small white bulb at the end, that points more towards an effluvium. If they vary clearly in thickness and many of them are short and fine, that points more towards miniaturisation. This is a guide for your doctor’s appointment and explicitly not a diagnosis.

Is it really the pill? The most common mix-ups

A diffuse effluvium always looks the same, no matter what triggered it. That is why the pill is often suspected when a second cause is behind it or contributing as well. Four mix-ups are particularly common, and three of them can be clarified with a blood test.

Iron deficiency. Especially relevant after stopping, because your own bleeding returns. The storage marker ferritin says more here than haemoglobin. Target values of 40 to 70 nanograms per millilitre for the hair come from individual expert opinions (Rushton 2002, Trost et al. 2006) and are not confirmed by randomised controlled trials. Details in the article on iron deficiency and hair loss.

Thyroid. Both an underactive and an overactive thyroid can trigger diffuse hair loss, and Hashimoto’s thyroiditis does not in principle rule out taking the pill. The first value to check is TSH. More on this in our guide to hair loss and the thyroid.

PCOS. By raising SHBG, the pill can clinically mask an existing hyperandrogenaemia. If cycle problems, acne and hair loss appear together after stopping, that can point to a previously masked polycystic ovary syndrome. There are no reliable frequency figures on this, and the investigation follows the established diagnostic criteria for polycystic ovary syndrome.

Telogen effluvium from another cause. Crash diets with heavy weight loss, feverish infections, surgery, periods of high stress and new medicines all produce the same picture. If you had any of these in the period in question, mention it at your appointment: see hair loss from medication and diffuse hair loss.

A cycle-related pattern has also been described and is often confused with the pill. Why cycle-related hair loss is a topic of its own for many women is explained in the linked article.

The morning-after pill often comes up as a suspect in forums. A single high dose of hormones with levonorgestrel or ulipristal acetate is mechanistically plausible as a trigger of telogen effluvium, with the typical delay described above. This has not been systematically studied, and no reliable figures exist for it.

When is medical help for hair loss urgently needed?

Hair loss needs urgent medical attention, meaning without months of waiting first, when it no longer fits an effluvium. Two observations are decisive here: round, sharply defined bald patchesas they occur with alopecia areata (dermatological treatment guidelines exist specifically for this), and hair loss with an itchy, flaking, weeping or painful scalp.

Neither of these is a hormonal effluvium, and neither waits for the timeline in this article. Scarring forms can destroy follicles permanently, and the earlier they are treated, the more can be preserved. The same applies if the hair loss comes with severe exhaustion, cycle problems or a marked change in weight.

What to do about hair loss from the pill

With hair loss from the pill three steps make sense, and in this order: document it, have it medically assessed, accept the timeline. What does not make sense in the first few weeks: changing anything about your product on your own or supplementing on suspicion.

Who is responsible for what? Your GP or sexual health clinic for everything to do with the product and your cycle; dermatology for assessing the scalp and the hair pattern with trichoscopy and a pull test. Often you need both. Which speciality makes sense when is explained in the article hair loss: which doctor can help .

Useful tests, phrased as something to raise at your appointment: a full blood count and ferritin, TSH and, if anything is abnormal, fT3, fT4 and TPO antibodies, 25-OH vitamin D, and zinc and vitamin B12 if there is a corresponding suspicion. An androgen panel with testosterone, DHEAS, SHBG and prolactin only belongs in there if hyperandrogenism is suspected. Which values stand for what is explained in our guide to the blood test for hair loss.

One limitation that is stated almost nowhere: A hormone panel is only of limited value while you are still taking the pill, because the product suppresses your own hormone production and raises SHBG. The Society for Endocrinology guideline on the evaluation of androgen excess in women (Elhassan et al., Clinical Endocrinology 2025) recommends an interval of three months since the last dose before such values are measured.

Whether that interval makes sense at all in your case is for your doctor to decide. Nobody stops a contraceptive just to be able to measure a lab value.

When do you see the hair growing back?

The resting phase lasts around three to five months, and hair grows at about 1 cm a month (NIH StatPearls, “Physiology, Hair”). New hairs are therefore visible as short stubble after three to four months at the earliest, and only after six to nine months as volume. If you judge after four weeks, you are inevitably judging too early.

In the meantime, what makes sense: correcting confirmed deficiencies specifically, eating enough protein, treating your hair gently. What does not make sense: combination supplements without a blood result. The timeline further up shows when an assessment makes sense at all.

Can I still wash and brush normally with hair loss from the pill?

Yes. With telogen effluvium, washing, combing and brushing do not trigger any additional hair loss. The hairs that stay in your hand are already detached from the papilla in the resting phase and are only held mechanically in the hair canal. Washing rinses out what is loose anyway; it does not decide how many follicles go into the resting phase.

Washing less often therefore only shifts the amount: if you wash every three days instead of daily, you find roughly three times as much in the plughole and get an even bigger fright. That changes nothing about the course, though it may well change something on your scalp, because sebum and flakes stay put.

What makes sense instead is gentle handling: do not rip through wet hair, detangle it from the ends with a wide-tooth comb, avoid tight braids and constant pull at the roots, reduce heat. That prevents breakage, which reduces density on top of everything else. There is one exception, and it concerns your doctor’s appointment: please do not wash your hair in the 24 hours before it, otherwise the pull test and the scalp assessment cannot be used.

Checklist for your doctor’s appointment

The strongest tool for your appointment is a simple timeline of your contraception. It makes the gap between the hormonal change and the shedding visible at a glance, and that gap is exactly what the question of cause hangs on.

What you can save yourself

With hair loss from the pill, one thing above all costs money and peace of mind: judging too early and treating on suspicion in the meantime. Hair care can improve the structure of the hair and prevent breakage, but it does not influence how many hairs are in the resting phase. That applies to shampoos, tonics and home remedies alike.

And what about the personal accounts? Forums are valuable for the feeling of not being alone with this, and misleading for the prognosis. The very women whose hair normalised on its own after eight months rarely post again. What is left behind are the long courses. That is a selection effect, not a statistic.

The pill against hair loss: when it is prescribed

There are combination products whose progestogen has an antiandrogenic partial activity , and they are used in gynaecology and dermatology in women with acne, hirsutism and androgenetic hair loss. Whether a pill against hair loss is even an option in an individual case is decided solely by the treating doctor.

This section answers the question that runs counter to the rest of the article: not the pill as a trigger, but the pill as a medically prescribed treatment. For an effluvium after stopping or after a switch it is not an option, because in that situation it is a matter of time and of finding a second trigger. The topic only becomes relevant with a hereditary, partly androgen-driven form.

The progestogens with an antiandrogenic effect include cyproterone acetate, chlormadinone acetate, dienogest and drospirenone. The strength of the effect differs markedly between them. The difference in approved indications matters: for some combinations, acne and hirsutism are approved indications, while use specifically for hair loss is predominantly off-label.

Cyproterone acetate is a special case: its use has been restricted since 2020, and that restriction applies in the UK as well. The European medicines regulator’s 2020 review limited its use because of the risk of meningiomas, which rises with the cumulative dose. Meningiomas were reported above all at daily doses of 25 mg and above. Products containing more than 10 mg may only be used when other treatment options, including lower doses, have been exhausted.

With an existing or previous meningioma, cyproterone acetate is contraindicated, and if one is found during treatment, the therapy has to be stopped permanently. The restrictions and monitoring recommendations of that European review also extend to lower-dose combination products containing 2 mg of cyproterone acetate, even though the highest risks are described for the high-dose uses.

The thrombosis risk belongs in the same paragraph as the effect. The European regulator’s risk assessment committee published risk figures by progestogen in 2014. What is decisive for this topic: the order of these risks does not line up with the effect on the hair.

Drospirenone is antiandrogenic and still sits in the upper risk group; levonorgestrel is androgenic and sits in the lower one. “Good for the hair” and “low risk of thrombosis” are two independent dimensions. That is why a product is not chosen because of the hair.

On top of that come the usual contraindications for combination products: smoking from the age of 35, migraine with aura, familial thrombophilia, certain pre-existing conditions and interactions with other medicines. Checking these is what the appointment is really about, not the hair question.

And what if the antiandrogenic pill is stopped again? Then the protective effect ends, as it does with any antiandrogenic treatment. In this situation the pill treats a symptom; it does not remove the predisposition. Reliable percentages for its effectiveness in hair loss are not available from randomised controlled trials, which is why you will not find any here.

For anyone who does not want to use contraception or cannot, the pill is not a hair loss treatment either. There are other routes for hormonally related hair lossthat a doctor needs to assess, and those belong in a conversation and not in an article.

Diffuse or hereditary? What that means for treatment

This distinction determines everything that follows. With a diffuse effluvium the follicles are present and are simply in the resting phase, so nothing is missing. With female pattern hair loss follicles shrink permanently, visible as a widening centre parting with a preserved front hairline.

The two often occur together, particularly after a hormonal change. That is exactly why a reliable assessment is difficult in the first year after stopping. The specialist reference for the hereditary form is now the European S3 guideline (Kanti et al., JEADV 2018), since the earlier German S1 guideline has expired.

A hair transplant is not indicatedfor hormonally related or diffuse hair loss, because no follicles are missing there; existing hairs are simply in the resting phase. It is only an option at all with a stable, patterned form and an intact donor area, and stable means at the earliest twelve months after a hormonal change and after a dermatological assessment.

That classification is exactly what is hard for non-specialists, and at the same time it is the question a dermatology appointment can do the most with. If you turn up with “my hair is falling out”, you get an open-ended search. If you turn up with “evenly across the whole scalp, since I stopped the pill, parting unchanged in width”, you have already sorted the appointment out.

If you would like a second look for this preliminary sorting, you can use our free hair analysis as a first step: a visual pattern analysis based on your photos that distinguishes diffuse thinning from miniaturisation along the centre parting. It is expressly not a substitute for a dermatological examination, a medical blood test or a gynaecological assessment; it is a point of orientation that lets you go into those appointments better prepared.

Frequently asked questions about hair loss from the pill

Sources